Lazard Asset Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-105
| Closed | -$1K | – | 2413 |
|
|
2024
Q3 | $1K | Buy |
+105
| New | +$1K | ﹤0.01% | 2168 |
|
|
2023
Q3 | – | Sell |
-67
| Closed | -$1K | – | 2384 |
|
|
2023
Q2 | $1K | Hold |
67
| – | – | ﹤0.01% | 2255 |
|
|
2023
Q1 | $3K | Hold |
67
| – | – | ﹤0.01% | 2188 |
|
|
2022
Q4 | $3K | Hold |
67
| – | – | ﹤0.01% | 2271 |
|
|
2022
Q3 | $5K | Hold |
67
| – | – | ﹤0.01% | 2183 |
|
|
2022
Q2 | $4K | Sell |
67
-1,582
| -96% | -$94.4K | ﹤0.01% | 2262 |
|
|
2022
Q1 | $182K | Sell |
1,649
-454
| -22% | -$50.1K | ﹤0.01% | 1273 |
|
|
2021
Q4 | $202K | Buy |
+2,103
| New | +$202K | ﹤0.01% | 1279 |
|
|
2021
Q3 | – | Sell |
-382
| Closed | -$59K | – | 2224 |
|
|
2021
Q2 | $59K | Sell |
382
-115
| -23% | -$17.8K | ﹤0.01% | 1532 |
|
|
2021
Q1 | $78K | Sell |
497
-1,559
| -76% | -$245K | ﹤0.01% | 1267 |
|
|
2020
Q4 | $477K | Buy |
+2,056
| New | +$477K | ﹤0.01% | 982 |
|
|
2020
Q2 | – | Sell |
-198
| Closed | -$57K | – | 1706 |
|
|
2020
Q1 | $57K | Buy |
+198
| New | +$57K | ﹤0.01% | 1131 |
|